VK
Vijay Kumar Joshi
About Vijay Kumar Joshi
Data last updated:
Vijay Kumar Joshi is a Director at Sanctus Global Formulations Limited (since 2016), Director at Sanctus Global Lifesciences Private Limited (since 2017) and Director at Vikson Securities Private Limited (since 1995), and holds 1 more current directorship. The companies operate in Pharma and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹48.65 Cr; the largest is Sanctus Global Formulations Limited at ₹47.05 Cr (FY 2025). Earlier, Vijay Kumar Joshi was a Director at Scott Edil Pharmacia Limited (2017–2019) and Director at Scott-Edil Advance Research Laboratories & Education Limited (2017–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sanctus Global Formulations Limited U29297CH2000PLC041530 | Director | 01 Oct 2016 | 2000 | ₹47.05 Cr (FY 2025) | Active |
 Sanctus Global Lifesciences Private Limited U51909CH2017PTC041369 | Director | 06 Feb 2017 | 2017 | ₹1.46 Cr (FY 2025) | Active |
 Vikson Securities Private Limited U65921CH1995PTC016503 | Director | 29 May 1995 | 1995 | ₹13.2 Lakh (FY 2024) | Active |
| Vikson Commodities Pvt Ltd U45202CH2006PTC030157 | Director | 27 Apr 2006 | 2006 | ₹90,901 (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Scott Edil Pharmacia Limited U24232CH2003PLC025699 | Director | 15 Sep 2017 | 2003 | ₹848 Cr (FY 2025) | Active |
| Scott-Edil Advance Research Laboratories & Education Limited U24232CH2009PLC031649 | Director | 15 Sep 2017 | 2009 | ₹418 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vijay Kumar Joshi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sahil Joshi | 07669407 | Sanctus Global Formulations Limited , Sanctus Global Lifesciences Private Limited | Director |
| Sangeeta Joshi | 07802762 | Sanctus Global Formulations Limited , Vikson Securities Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vijay Kumar Joshi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vijay Kumar Joshi
Vijay Kumar Joshi currently holds 4 directorships: Sanctus Global Formulations Limited (Director, since 01 Oct 2016, revenue ₹47.05 Cr (FY 2025)); Sanctus Global Lifesciences Private Limited (Director, since 06 Feb 2017, revenue ₹1.46 Cr (FY 2025)); Vikson Securities Private Limited (Director, since 29 May 1995, revenue ₹13.2 Lakh (FY 2024)); Vikson Commodities Pvt Ltd (Director, since 27 Apr 2006, revenue ₹90,901 (FY 2024)).
Vijay Kumar Joshi was first appointed on 29 May 1995 as Director at Vikson Securities Private Limited. The most recent appointment on record is 15 Sep 2017 at Scott-Edil Advance Research Laboratories & Education Limited.
The 4 current companies of Vijay Kumar Joshi that report revenue have a combined latest revenue of ₹48.65 Cr: Sanctus Global Formulations Limited ₹47.05 Cr (FY 2025); Sanctus Global Lifesciences Private Limited ₹1.46 Cr (FY 2025); Vikson Securities Private Limited ₹13.2 Lakh (FY 2024); Vikson Commodities Pvt Ltd ₹90,901 (FY 2024).
Vijay Kumar Joshi held 2 earlier board appointments: Scott Edil Pharmacia Limited (Director, 15 Sep 2017 to 30 Aug 2019); Scott-Edil Advance Research Laboratories & Education Limited (Director, 15 Sep 2017 to 30 Aug 2019).
The current boards of Vijay Kumar Joshi's companies include Sahil Joshi (Sanctus Global Formulations Limited), Sangeeta Joshi (Sanctus Global Formulations Limited).